OA10436A - New applications of lysozyme dimer - Google Patents

New applications of lysozyme dimer Download PDF

Info

Publication number
OA10436A
OA10436A OA70048A OA70048A OA10436A OA 10436 A OA10436 A OA 10436A OA 70048 A OA70048 A OA 70048A OA 70048 A OA70048 A OA 70048A OA 10436 A OA10436 A OA 10436A
Authority
OA
OAPI
Prior art keywords
use according
lysozyme
composition
group
fish
Prior art date
Application number
OA70048A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of OA10436A publication Critical patent/OA10436A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fish Paste Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA70048A 1995-01-13 1997-07-11 New applications of lysozyme dimer OA10436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07

Publications (1)

Publication Number Publication Date
OA10436A true OA10436A (en) 2001-12-07

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
OA70048A OA10436A (en) 1995-01-13 1997-07-11 New applications of lysozyme dimer

Country Status (38)

Country Link
EP (2) EP1086703A3 (ru)
JP (1) JPH10511974A (ru)
KR (1) KR100420377B1 (ru)
CN (1) CN1090506C (ru)
AP (2) AP628A (ru)
AT (1) ATE218367T1 (ru)
AU (1) AU709620B2 (ru)
BA (1) BA96074A (ru)
BG (1) BG62239B1 (ru)
BR (1) BR9606973A (ru)
CA (1) CA2210091A1 (ru)
CZ (1) CZ293353B6 (ru)
DE (2) DE69621589D1 (ru)
DZ (1) DZ1964A1 (ru)
EA (1) EA001462B1 (ru)
EE (1) EE9700154A (ru)
ES (1) ES2109208T1 (ru)
FI (1) FI972943A0 (ru)
GB (1) GB2311724B (ru)
GE (1) GEP20012571B (ru)
GR (1) GR970300047T1 (ru)
HK (1) HK1002060A1 (ru)
HR (1) HRP960014A2 (ru)
HU (1) HU223903B1 (ru)
IL (1) IL116737A (ru)
MA (1) MA23775A1 (ru)
MD (1) MD1633C2 (ru)
MY (1) MY132437A (ru)
NO (1) NO973203D0 (ru)
NZ (1) NZ298432A (ru)
OA (1) OA10436A (ru)
PL (1) PL185678B1 (ru)
SK (1) SK94297A3 (ru)
SV (1) SV1996000001A (ru)
TN (1) TNSN96004A1 (ru)
TR (1) TR199700633T1 (ru)
UA (1) UA50728C2 (ru)
WO (1) WO1996021463A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
IL139209A0 (en) * 1998-04-27 2001-11-25 Nika Health Products Ltd Lysozyme dimers and methods utilizing the same
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
WO2008109401A2 (en) * 2007-03-02 2008-09-12 Saint Simeon Lda Composition and method for treating papilloma virus and equine sarcoids
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
WO2015090906A1 (en) * 2013-12-18 2015-06-25 Dsm Ip Assets B.V. Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
EP0300031A4 (en) * 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
ES2086403T3 (es) * 1990-01-08 1996-07-01 Nika Health Products Ltd Procedimiento para la elaboracion de dimeros de ribonucleasa.
RO114805B1 (ro) * 1990-01-08 1999-07-30 Nika Health Products Ltd Vaduz Dimer de lizozim purificat si procedeu de obtinere a acestuia
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
EA001462B1 (ru) 2001-04-23
WO1996021463A2 (en) 1996-07-18
BR9606973A (pt) 1999-01-26
HUP9801689A3 (en) 2000-07-28
MD1633C2 (ru) 2001-10-31
CZ293353B6 (cs) 2004-04-14
MD1633B2 (en) 2001-03-31
SK94297A3 (en) 1998-01-14
EP1086703A2 (en) 2001-03-28
GB2311724B (en) 1999-07-21
ES2109208T1 (es) 1998-01-16
AU709620B2 (en) 1999-09-02
MD970244A (en) 1999-05-31
AU4391696A (en) 1996-07-31
IL116737A (en) 2000-02-17
MY132437A (en) 2007-10-31
GR970300047T1 (en) 1997-12-31
PL321546A1 (en) 1997-12-08
TNSN96004A1 (fr) 2005-03-15
UA50728C2 (ru) 2002-11-15
BG62239B1 (bg) 1999-06-30
CA2210091A1 (en) 1996-07-18
AP871A (en) 2000-09-10
TR199700633T1 (xx) 1998-01-21
PL185678B1 (pl) 2003-07-31
EE9700154A (et) 1997-12-15
HUP9801689A2 (hu) 1998-10-28
GEP20012571B (en) 2001-11-26
EP1086703A3 (en) 2001-05-02
MA23775A1 (fr) 1996-10-01
CN1177303A (zh) 1998-03-25
CZ220297A3 (cs) 1998-02-18
EA199700101A1 (ru) 1997-12-30
IL116737A0 (en) 1996-05-14
BG101709A (en) 1998-03-31
EP0804227B1 (en) 2002-06-05
BA96074A (bs) 1999-08-02
GB9714354D0 (en) 1997-09-10
AP9600783A0 (en) 1996-04-30
AP628A (en) 1998-02-27
NO973203L (no) 1997-07-10
AP9701024A0 (en) 1997-07-31
JPH10511974A (ja) 1998-11-17
DE804227T1 (de) 1998-04-09
KR19980701337A (ko) 1998-05-15
ATE218367T1 (de) 2002-06-15
NO973203D0 (no) 1997-07-10
SV1996000001A (es) 1997-02-17
DZ1964A1 (fr) 2002-10-15
HU223903B1 (hu) 2005-03-29
CN1090506C (zh) 2002-09-11
GB2311724A (en) 1997-10-08
FI972943A (fi) 1997-07-11
EP0804227A2 (en) 1997-11-05
HK1002060A1 (en) 1998-07-31
NZ298432A (en) 2001-03-30
KR100420377B1 (ko) 2004-05-20
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
WO1996021463A3 (en) 1996-09-19
HRP960014A2 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
CS277030B6 (en) Antiviral and antibacterial agent
AP871A (en) New applicants of lysozyme dimer.
CN1838885A (zh) 治疗皮肤的疮和损害的方法
JPH11504000A (ja) 造血前駆細胞の増殖を促進するチオール類
US6183742B1 (en) Applications of lysozyme dimer
WO2005068491A1 (fr) Peptides antitumoraux et antiviraux
JP3631245B2 (ja) DNAウイルス感染の治療のための薬物の製造のための膜翅類昆虫(hymenoptera)毒の使用
KR100302994B1 (ko) 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용
KR20060038387A (ko) 화학요법을 받고 있는 암 환자를 치료하는 방법
HRP20100108A2 (hr) Upotreba ramnolipida kao lijeka izbora u slučaju nuklearnih katastrofa za liječenje kombiniranih radijacijskih ozljeda i bolesti u ljudi i životinja
US20020098171A1 (en) New application of lysozyme dimer
MXPA97005246A (en) New applications of dimero de lisoz
JPH01313433A (ja) 抗hiv剤
RU2794852C1 (ru) Способ повышения естественной резистентности молодняка крупного рогатого скота
RU2414223C1 (ru) Средство, обладающее иммуностимулирующим и гемостимулирующим действием
RU2133616C1 (ru) Иммунотропное средство
Abdullaeva et al. To Study the Effectiveness of “Maysara” Wheat Sprouts Powder in the Treatment of Iron Deficiency Anemia Tashkent Medical Academy
Cristina et al. Propolis' activity on some blood parameters in rats.
WO2022055388A1 (ru) Способ лечения алеутской болезни норок
WO2005042015A1 (fr) Composition pharmaceutique anti-herpetique, procede de production d'une forme medicamenteuse a partir de cette composition et procede d'utilisation correspondant
WO2004064849A1 (fr) Produit normalisant la structure et les fonctions des organes et tissus, stimulant les reparations des lesions et possedant une activite antivirale
CN116271057A (zh) 一种预防或治疗滤泡淋巴瘤的联合用药物组合物及其应用
RU2371187C1 (ru) Способ лечения паралича и эпилепсии у собак
JPH0219325A (ja) 感染症を防除するためのヒト免疫グロブリンおよびインターロイキン―2の組み合わせ
BG99266A (en) Form for the treatment of viral diseases